Objective
Scientific discoveries on mechanisms of biomedical processes and invention of technologies to repair disease-related genes or destroy cancer cells represent the foundation of an important pillar of personalized medicine. The new Centre of Excellence for the Technologies of Gene and Cell Therapy (CTGCT) will be the first Centre of Excellence in biomedicine in Slovenia and unique with an approach combining mammalian cell synthetic biology and immunology to develop novel technologies for the development of GCTs and cancer immunotherapy in the EU and beyond. The aim of CTGCT is to become one of the leaders in the interdisciplinary breakthrough science technologies for GCT and a model for international research excellence, industrial collaboration and public engagement.
CTGCT will gain a competitive edge based on the vertical integration of the technologies for whose further development the foundations have been laid at the National Institute of Chemistry (SI), and with support of expertise and knowledge of the advanced partners University College London (UK), University Medical Centre Utrecht (NL), Charité – Universitätsmedizin Berlin (DE) and Technical University Dresden (DE). Supported by the involvement of clinicians and patient organizations, CTGCT will enable translation of research achievements into therapeutic applications, primarily neurological and rare genetic diseases and cancer immunotherapy, and establish a capacity to prepare the GMP clinical grade therapeutic reagents, which is currently a bottleneck to effective translation.
By bridging gap in translation, CTGCT will facilite high impact of excellent research and innovation on health in Slovenia as well as in the West Balkans, East Europe and beyond. It will strengthen scientific capabilities and long-term collaborations with partners and others leading scientific institutions from abroad, as well as improve accessibility of the GCTs.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- medical and health sciences clinical medicine oncology
- medical and health sciences basic medicine immunology immunotherapy
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
HORIZON.4.1 - Widening participation and spreading excellence
MAIN PROGRAMME
See all projects funded under this programme -
HORIZON.4.1.1 - Teaming
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
HORIZON-CSA - HORIZON Coordination and Support Actions
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) HORIZON-WIDERA-2022-ACCESS-01-two-stage
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
1000 Ljubljana
Slovenia
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.